Treatment of fabry disease with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS) Lenders M, Nordbeck P, Kurschat C, Eveslage M, Karabul N, Kaufeld J, Hennermann JB, Patten M, Cybulla M, Müntze J, Üçeyler N, Liu D, Das AM, Sommer C, Pogoda C, Reiermann S, Duning T, Gaedeke J, von Cossel K, Blaschke D, Brand SM, Alexander Mann W, Kampmann C, Muschol N, Canaan-Kühl S, Brand E (2022) In: European Heart Journal - Cardiovascular Pharmacotherapy, 8. Research article (journal)
Precision medicine in Fabry disease Lenders M, Brand E (2021) In: Nephrology, Dialysis and Transplantation, 36. Research article (journal)
Generation and Characterization of a Polyclonal Human Reference Antibody to Measure Anti-Drug Antibody Titers in Patients with Fabry Disease Lenders M, Scharnetzki D, Heidari A, Di Iorio D, Wegner SV, Brand E (2021) In: International Journal of Molecular Sciences, 22. Research article (journal)
Fabry Disease: The Current Treatment Landscape Lenders M, Brand E (2021) In: Drugs, 81. Research article (journal)
Neutralising anti-drug antibodies in Fabry disease can inhibit endothelial enzyme uptake and activity Stappers F, Scharnetzki D, Schmitz B, Manikowski D, Brand SM, Grobe K, Lenders M, Brand E (2020) In: ((Bitte Journal prüfen)), 2020. Research article (journal)

Zielgerichtete endogene Genaktivierung der α-Galaktosidase A als möglicher Therapieansatz bei Morbus Fabry Duration: 01/01/2018 - 30/04/2019 Type of project: Own resources project
Observational approach (pilot project): “Lift Yourself” program – safe physical exercise in Fabry Disease (Fabry and Sport) Duration: 01/08/2014 - 31/03/2016 Type of project: Own resources project
Mechanismen der Endothelzell- und Gefäßsteifigkeit in Abhängigkeit vom genetischen Status Duration: 01/06/2011 - 31/05/2014 Funded by: Else Kröner-Fresenius-Foundation Type of project: Individual project